Parathyroid Carcinoma: Analysis of Patient Characteristics and Outcomes in a Retrospective Review of Eight Cases seen in a Single Center

Shamira Shahar, Kim Piow Lim, Masni Mohamad


Eight cases of parathyroid carcinoma were identified (8 females; median age 45 years, range 28-72). Half of whom were diagnosed preoperatively. Hypercalcemic symptoms were seen in 87.5% of the patients and the main complication was nephrolithiasis. At presentation, the median calcium was 3.675 mmol/L, median phosphate of 0.68 mmol/L, median intact parathyroid hormone (iPTH) was 211 pmol/L. Five patients had regional nodes metastasis and 1 had distant metastasis to the lungs. Parathyroid gland invasion to adjacent structures was seen in 62.5% of cases while another 62.5% showed capsular or vascular infiltration on histology with median tumour size of 3.2 cm. Recurrent hypercalcemia occurred in 50% of the patients with median time of recurrence of 21 months. In this case series, we found that patients with severe hypercalcemia and high iPTH also exhibited a high index suspicion of PC.


parathyroid neoplasms, carcinoma, hypercalcemia

Full Text:

Abstract HTML PDF


De Quervain F. Parastruma maligna aberrata. Deutsche Zeitschr Chir. 1904;100:334-52.

Obara T, Fujimoto Y. Diagnosis and treatment of patients with

parathyroid carcinoma: An update and review. World J Surg.

;15(6):738-44. PMID: 1767540.

Shane E. Clinical review 122: Parathyroid carcinoma. J Clin Endocrinol Metab. 2001;86(2):485-93. PMID: 11157996.

Favia G, et al. La patologia chirurgica della tiroide e delle

paratiroidi. Club delle UEC; Il carcinoma delle paratiroidi; 2000.

Kebebew E. Parathyroid carcinoma. Curr Treat Options Oncol.

;2(4):347–54. PMID: 12057115.

Heath H 3rd, Hodgson SF, Kennedy MA. Primary hyperparathyroidism:Incidence, morbidity, and potential economic impact in a community. N Engl J Med. 1980;302(4):189-93. PMID: 7350459.

Silverberg SJ, Shane E, Jacobs TP, et al. Nephrolithiasis and bone involvement in primary hyperparathyroidism. Am J Med. 1990;89(3):327-34. PMID: 2393037. (90)90346-f.

Wynne AG, van Heerden J, Carney JA, Fitzpatrick LA. Parathyroid carcinoma: Clinical and pathological features in 43 patients. Medicine.1992;71(4):197-205. PMID: 1518393.

Levin KE, Galante M, Clark OH. Parathyroid carcinoma versus

parathyroid adenoma in patients with profound hypercalcemia.

Surgery. 1987;101(6):649-60. PMID: 3589961.

Sidhu PS, Talat N, Patel P, Mulholland NJ, Schulte KM. Ultrasound features of malignancy in the preoperative diagnosis of parathyroid cancer: A retrospective analysis of parathyroid cancer. Eur Radiol. 2011;21(9):1865-73. PMID: 21556910.

Daly BD, Coffey SL, Behan M. Ultrasonography appearances of

parathyroid carcinoma. Br J Radiol. 1989; 62(743):1017-9. PMID:

Schantz A, Castleman B. Parathyroid carcinoma. A study of 70 cases. Cancer. 1973;31(3):600-5. PMID: 4693587.<600::aid-cncr2820310316>;2-0.

Delellis RA. Challenging lesions in the differential diagnosis of

endocrine tumors: Parathyroid carcinoma. Endocr Pathol. 2008;

(4):221-5. PMID: 19058032.

Koea JB, Shaw JH. Parathyroid cancer: Biology and management. Surg Oncol. 1999;8(3):155-65. PMID: 11113666.

Pandya C, Uzilov AV, Bellizzi J, et al. Genomic profiling reveals

mutational landscape in parathyroid carcinomas. JCI Insight.

;2(6):e92061. PMID: 28352668. PMCID: PMC5358487.

Sandelin K, Auer G, Bondeson L, Grimelius L, Farnebo LO. Prognostic factors in parathyroid cancer: A review of 95 cases. World J. Surg.1999;16(4):724-31. PMID: 1413841.

Schulte KM, Talat N, Galata G, et al. Oncologic resection achieving r0 margins improves disease-free survival in parathyroid cancer. Ann Surg Oncol. 2014;21(6):1891-7. PMID: 24522991.

Kebebew E, Arici C, Duh QY, Clark OH. Localization and reoperation results for persistent and recurrent parathyroid carcinoma. Arch Surg. 2001;136(8):878-85. PMID: 11485522.

Wei CH, Harari A. Parathyroid carcinoma: Update and guidelines for management. Curr Treat Options Oncol. 2012;13(1):11-23. PMID:22327883.

Rolighed, L, Rejnmark L, Sikjaer T, et al. Vitamin D treatment in

primary hyperparathyroidism: A randomized placebo controlled trial.

J Clin Endocrinol Metab. 2014;99(3):1072-80. PMID: 24423366.

Dudney WC, Bodenner D, Stack Jr BC. Parathyroid carcinoma.

Otolaryngol Clin North Am. 2010;43(2):441-53. PMID: 20510726.

Tong CV, Hussein Z, Noor NM, Mohamad M, Ng WF. Use of denosumab in parathyroid carcinoma with refractory hypercalcemia, QJM. 2015;108(1):49–50. PMID: 25099611.

Silverberg SJ, Rubin MR, Faiman C, et al. Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma. J Clin Endocrinol Metab. 2007;92(10):3803-8. PMID:17666472.

Harari A, Waring A, Fernandez-Ranvier G, et al. Parathyroid

carcinoma: A 43-year outcome and survival analysis. J Clin Endocrinol Metab. 2011;96(12):3679-86. PMID: 21937626.

Busaidy NL, Jimenez C, Habra MA, et al. Parathyroid carcinoma: A 22-year experience. Head Neck. 2004;26(8):716-26. PMID: 15287039.